Kura Oncology (KURA) Tops Q3 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.50), $0.04 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Vireo Growth completes acquisition of C21 Investments